NCT04070053View on ClinicalTrials.gov

Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway

NACompletedINTERVENTIONAL
Enrollment

920

Participants

Timeline

Start Date

August 23, 2019

Primary Completion Date

March 16, 2021

Study Completion Date

March 30, 2022

Conditions
Acute Respiratory Distress SyndromeHypoxemic Respiratory FailureARDS, Human
Interventions
OTHER

TheraPPP Pathway

"TheraPPP Steps:~Step 1. All mechanically ventilated patients will have a height measured and documented. Step 2. Screening for HRF. Step 3. Initiate Lung Protective Ventilation (LPV). Step 4. Paralysis. Step 5. Prone Positioning."

Trial Locations (1)

T2N 2T9

Foothills Hospital Intensive Care Unit, Calgary

All Listed Sponsors
collaborator

Alberta Health services

OTHER

lead

University of Calgary

OTHER

NCT04070053 - Treatment of Hypoxemic Respiratory Failure and ARDS With Protection, Paralysis, and Proning (TheraPPP) Pathway | Biotech Hunter | Biotech Hunter